<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7806090</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6166</journal-id>
<journal-id journal-id-type="nlm-ta">Neurosci Biobehav Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci Biobehav Rev</journal-id>
<journal-title-group>
<journal-title>Neuroscience and biobehavioral reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0149-7634</issn>
<issn pub-type="epub">1873-7528</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28506926</article-id>
<article-id pub-id-type="pmc">5682234</article-id>
<article-id pub-id-type="doi">10.1016/j.neubiorev.2017.05.011</article-id>
<article-id pub-id-type="manuscript">NIHMS878873</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High times for cannabis: epigenetic imprint and its legacy on brain and behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Szutorisz</surname>
<given-names>Henrietta</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hurd</surname>
<given-names>Yasmin L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Friedman Brain Institute, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff>
<aff id="A2">
<label>2</label>Friedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be addressed: Dr. Yasmin L. Hurd, Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1065, New York, NY 10029, USA, Tel.: +1 212 824 8314, Fax: +1 646 527 9598, <email>yasmin.hurd@mssm.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>85</volume>
<fpage>93</fpage>
<lpage>101</lpage>
<!--elocation-id from pubmed: 10.1016/j.neubiorev.2017.05.011-->
<abstract>
<p id="P2">Extensive debates continue regarding marijuana (<italic>Cannabis spp</italic>), the most commonly used illicit substance in many countries worldwide. There has been an exponential increase of cannabis studies over the past two decades but the drug’s long-term effects still lack in-depth scientific data. The epigenome is a critical molecular machinery with the capacity to maintain persistent alterations of gene expression and behaviors induced by cannabinoids that have been observed across the individual’s lifespan and even into the subsequent generation. Though mechanistic investigations regarding the consequences of developmental cannabis exposure remain sparse, human and animal studies have begun to reveal specific epigenetic disruptions in the brain and the periphery. In this article, we focus attention on long-term disturbances in epigenetic regulation in relation to prenatal, adolescent and parental germline cannabinoid exposure. Expanding knowledge about the protracted molecular memory could help to identify novel targets to develop preventive strategies and treatments for behaviors relevant to neuropsychiatric risks associated with developmental cannabis exposure.</p>
</abstract>
<kwd-group>
<kwd>cannabinoid</kwd>
<kwd>prenatal development</kwd>
<kwd>adolescence</kwd>
<kwd>multigenerational inheritance</kwd>
<kwd>epigenetics</kwd>
<kwd>DNA methylation</kwd>
<kwd>chromatin</kwd>
<kwd>transcription</kwd>
<kwd>synaptic plasticity</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>